XML 21 R25.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Warrant Derivative Liability (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2014
Derivative Liabilities [Abstract] |
Fair Value Measurements, Nonrecurring | Warrants were determined to have a fair value per share and aggregate value as of June 30, 2014 and in aggregate value as of June 30, 2013 as follows:
|  | Issued Warrants |  |  |  | Fair Value Per Share $ as of June 30, 2014 |  |  | Total Fair Value in Aggregate $ as of June 30, 2014 |  |  | Total Fair Value in Aggregate $ as of June 30, 2013 |
June 2012 Warrants |  |  | 562,551 |  | $ |  |  | 0.20 |  |  | $ | 110,000 |  |  | $ | 27,000 |
July 2012 Warrants |  |  | 338,013 |  | $ |  |  | 0.20 |  |  | $ | 67,000 |  |  | $ | 17,000 |
August 2012 Warrants |  |  | 120,719 |  | $ |  |  | 0.20 |  |  | $ | 24,000 |  |  | $ | 6,000 |
October 2012 Warrants |  |  | 48,287 |  | $ |  |  | 0.20 |  |  | $ | 10,000 |  |  | $ | 3,000 |
Advisory Agreement Warrants |  |  | 1,837,777 |  | $ |  |  | 0.20 |  |  | $ | 360,000 |  |  | $ | 90,000 |
Total |  |  | 2,907,347 |  |  |  |  |  |  |  | $ | 571,000 |  |  | $ | 143,000 |
Fair Value, Concentration of Risk | Significant assumptions used to estimate the fair value of the warrants classified as derivative liabilities at June 30, 2014 are summarized below:
Risk-free interest rate |  |  | 1.00% – 0.86 | %
Expected life (average) |  |  | 2.96 - 3.17 years |
Stock price (based on prices on valuation date) |  | $ | 0.30 |
Exercise price |  | $ | 0.26 |
Expected volatility |  |  | 100 | %

X
- Details
Name: | us-gaap_DerivativeLiabilitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19296-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. The disclosure concerning concentrations of risk may consist of the following information: (1) for concentrations of credit risk disclosure may include: (a) information about the (shared) activity, region, or economic characteristic that identifies the concentration, (b) the maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity, (c) the policy of requiring collateral or other security to support financial instruments subject to credit risk, information about the entity's access to that collateral or other security, and the nature and a brief description of the collateral or other security supporting those financial instruments, and (d) the policy of entering into master netting arrangements to mitigate the credit risk of financial instruments, information about the arrangements for which the entity is a party, and a brief description of the terms of those arrangements, including the extent to which they would reduce the entity's maximum amount of loss due to credit risk and (2) for disclosure of quantitative information about the market risks of financial instruments that is consistent with the way the company manages or adjusts those risks, disclosure may include: (a) more details about current positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income, of several possible changes in market prices, (c) a gap analysis of interest rate re-pricing or maturity dates, (d) the duration of the financial instruments, (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average value at risk during the year, or (f) other ways of reporting quantitative information as internally developed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13531-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13537-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 23 -URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13587-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13572-108611 + Details
Name: | us-gaap_FairValueConcentrationOfRiskTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration